Eisai Is Pioneering Alzheimer’s Research and Working to Improve the Experience of People Living With the Disease
“Never giving up” is the message Eisai Co., Ltd., emphasizes when it comes to the company’s four decades of Alzheimer’s research. The global pharmaceutical company headquartered in Tokyo, with its U.S. headquarters in New Jersey, is focused on developing innovative solutions for people and families living with Alzheimer’s disease (AD) and other neurodegenerative diseases.
Don't worry. Be healthy.